Login · Register

Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.

Research Area · Vascular Disease

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords
13571 13,14-dihydro-15-keto-tetranor Prostaglandin F1α Exclusive 24379-94-0 ≥98% ✓ 2009-11-05 0.672636114312 13-14-dihydro-15-keto-tetranor-prostaglandin-f1 metabolites PGF1α PGF2α tetranors PGFM prostaglandins PGs urinary metabolites prostanoic acids C13 C-13 C14 C-14 C15 C-15
10004946 14,15-EE-5(Z)-E Exclusive 519038-92-7 >98% ✓ 2007-01-15 70.353480662983 14-15-ee-5-z-e 14,15-Epoxyeicosa-5(Z)-enoic Acid 14,15-EpETrE 14,15-EETs antagonists hypertension vasodilation vasodilator vasoconstriction vasoconstrictor EDHT endothelium-derived hyperpolarizing factor U46619 bovine arteries endocrinology EEZE
10010486 14,15-EE-8(Z)-E Exclusive 519038-93-8 ≥98% ✓ 2008-11-03 23.675408839779 14-15-ee-8-z-e 14,15-Epoxyeicosa-8(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE
10008510 15(R)-Pinane Thromboxane A2 - >98% 2006-06-14 0E-12 15-r-pinane-thromboxane-a2 15(R)-PTA2 TXA2 anatagonists TP receptors synthases platelets aggregation analogs inhibits inhibitors inhibition U-46619 cat coronary artery constriction 15-epimer
10010635 (±)16-HETE - ≥98% 2008-06-09 18.474401473297 -16-hete CYP450 eicosanoid metabolism kidneys ATPase ion transport vasodilation renal hypertension
10010638 (±)18-HETE Exclusive - ≥97% ✓ 2008-06-13 2.100298342542 -18-hete CYP450 eicosanoid metabolism kidney vasodilation CYP2E1 20-HETE 20HETE 18HETE renal hypertension
10007767 19(R)-HETE 115461-39-7 >98% 2008-05-27 4.083977900552 19-r-hete hypertension arterioles CYP450 kidneys angiotensin II vasodilator vasoconstricition 20-HETE 19HETE 19-HETE renal 19 HETE
10007766 19(S)-HETE Exclusive New 115461-40-0 ≥98% ✓ 2010-04-06 2.041988950276 19-s-hete cytochromes P450 CYP450 metabolites arachidonic acids kidneys angiotensin II CYP2E1 vasodilators renal preglomerular vessels ATPase hypertension arterioles vasoconstriction
13050 1a,1b-dihomo Prostaglandin E1 - >98% 33.954972375690 1a-1b-dihomo-prostaglandin-e1 1a,1b-dihomo PGE1 1a,1b-dihomo-PGE1 prostaglandins
9000462 2,3-dinor-6-keto Prostaglandin F1α-d9 (sodium salt) New - ≥99% deuterated product 2010-05-07 40.331491712707 2-3-dinor-6-keto-prostaglandin-f1-d9-sodium-salt 2,3-dinor-6-keto PGF1α-d9 (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins PGs MS LC-MS LC/MS GC-MS GC/MS mass spectrometry deuterium deuterated
515121 2,3-dinor-6-keto Prostaglandin F1α EIA Kit - 2006-05-23 162.024033149171 2-3-dinor-6-keto-prostaglandin-f1-eia-kit 2,3-dinor-6-keto PGF1α ELISA Kit enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays
10008826 2,3-dinor-6-keto Prostaglandin F1α EIA Kit (Solid Plate) - 2006-05-23 123.186533149171 2-3-dinor-6-keto-prostaglandin-f1-eia-kit-solid-plate 2,3-dinor-6-keto PGF1α ELISA Kit enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction cyclooxygenases stroke COX-2 inhibits measures kits PGF1a assays
15120 2,3-dinor-6-keto Prostaglandin F1α (sodium salt) - ≥98% 40.975718232044 2-3-dinor-6-keto-prostaglandin-f1-sodium-salt 2,3-dinor-6-keto PGF1α (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins
13120 2,3-dinor Prostaglandin E1 7046-40-4 >98% 25.275837937385 2-3-dinor-prostaglandin-e1 2,3-dinor PGE1 prostaglandins 2,3-dinor-PGE1 erectile dysfunction
10006330 2,3-dinor Thromboxane B1 - >98% 2005-03-02 86.585003946329 2-3-dinor-thromboxane-b1 2,3-dinor TXB1 metabolites thromboxanes urine urinary 2,3-dinor-TXB2 11-dehydro TXB2 biosynthesis humans rats markers rabbits
10009315 6-Aminonicotinamide 329-89-5 ≥98% 2008-11-21 0.472375690608 6-aminonicotinamide 6-AN; NSC 21206; SR 4388 inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular
15210 6-keto Prostaglandin F1α 58962-34-8 >99% 73.638353591160 6-keto-prostaglandin-f1 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis
515211 6-keto Prostaglandin F1α EIA Kit - 353.000810313075 6-keto-prostaglandin-f1-eia-kit 6-keto Prostaglandin F1α ELISA Kit solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 41.464121546961 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards
18112 8,9-EE-14(Z)-E Exclusive - ≥95% ✓ 2009-03-15 6.380018416206 8-9-ee-14-z-e 8,9-Epoxyeicosa-14(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE
10007850 9,11-methane-epoxy Prostaglandin F1α 72517-81-8 >96% 2006-05-10 108.126279926335 9-11-methane-epoxy-prostaglandin-f1 9,11-Epoxymethano PGH1 prostaglandins PGs endoperoxides TXs thromboxanes prostacyclins PGH1 platelets smooth muscles analogs aggregation aorta aortic tracheas histamines coronary perfusion atherosclerosis
10010569 Acenocoumarol 152-72-7 ≥98% 2008-07-25 0.483465854968 acenocoumarol Sinthrome®; G-23350; Nicoumalone; Acenocoumarin; Sintrom® CYP450 thrombosis vitamin K warfarin bleeding blood coagulation inhibitors inhibits inhibition
10092 Adenosine Receptor A2A Blocking Peptide - 2009-04-03 199.064604051565 adenosine-receptor-a2a-blocking-peptide A2AR blocking peptides Western blots immunoblotting ARA2A
13523 Apelin-13 New 217082-58-1 ≥95% 2010-06-29 0E-12 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids
13079 ApoAI Blocking Peptide - 2008-09-30 9.689502762431 apoai-blocking-peptide Apolipoprotein A-I; Apolipoprotein AI antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots
13042 ApoAI Monoclonal Antibody (Clone CC3821C4) Exclusive - ✓ 2008-10-15 17.531325966850 apoai-monoclonal-antibody-clone-cc3821c4 Apolipoprotein AI antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins
13644 Aspalatone Exclusive 147249-33-0 ≥98% ✓ 2010-02-19 64.697395547684 aspalatone Acetylsalicylic Acid Matol ester antioxidants platelet aggregation thrombosis epilepsy kainic acid thromboembolism anti-platelets antiplateles
10010153 Aspirin™ Effect-Detection Kit - 2007-06-08 69.497127071823 aspirin-effect-detection-kit use:human 11-dehydro-TXB2 enzyme immunoassays ELISAs kits measures metabolites atherosclerosis thromboxanes eias analysistools:eia atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits atherosclerosis assays
10011131 BAY-41-8543 Exclusive 256498-66-5 ≥98% ✓ 2009-11-16 21.306701657458 bay-41-8543 soluble guanylate cyclase sGC nitric oxide NO GTP cyclic GMP cGMP agonist stimulator platelet aggregation blood pressure bleeding time thrombosis pulmonary hypertension BAY 41-8543 BAY 41 8543
10011135 BAY-60-7550 439083-90-6 ≥98% 2009-03-13 50.968139963168 bay-60-7550 inhibitors inhibits inhibition cyclic nucleotides cGMP cAMP cells signalling signaling PDE2 memory memories phosphodiesterase
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 112.584337016574 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 202.691795580110 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449
10010396 CAY10535 Exclusive - >98% ✓ 2008-05-06 292.683756906077 cay10535 TPbeta TPb TP.beta. TPalpha TP.alpha. TPa TXA2 thromboxanes antagonists platelet aggregations U-46619 U46619
10012447 CG 4305 New - ≥95% 2010-05-12 0E-12 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 83.827059545733 chemokine-like-receptor-1-polyclonal-antibody ChemR23; CMKLR1; DEZ; ChemerinR; Resolvin E1 Receptor; GPCR ChemR23 immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR
10009779 Cholesterol Cell-Based Detection Assay Kit - 2007-05-04 60.875331491712 cholesterol-cell-based-detection-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis fluorescent fluorometric assays cell-based assay cell based assays cba
10010948 DL-Propargyl Glycine (hydrochloride) - ≥98% 2008-08-19 1.685082872928 dl-propargyl-glycine-hydrochloride PAG (hydrochloride) H2S gasotransmitter inhibitor inhibits inhibition CSE vasodilation inflammation propargylglycine
10010380 ent-8-iso-15(S)-Prostaglandin F2α - ≥98% 2008-04-24 15.519401473296 ent-8-iso-15-s-prostaglandin-f2 ent-8-iso-15-epi-PGF2α; ent-15-epi-F2t-Isoprostane inhibitors inhibits inhibition 8-iso-PGF2.alpha. vasoconstriction platelet aggregation oxidative stress isoprostanes 15-F2t-isoprostane prostaglandins
10233 FABP3 Monoclonal Antibody (Clone CC68) - 2009-03-20 21.366427255984 fabp3-monoclonal-antibody-clone-cc68 Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting
10005368 Fenofibrate 49562-28-9 >98% 2004-09-15 34.996955801105 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology
10006407 FTY720 (R)-Phosphate Exclusive 402616-23-3 ≥98% ✓ 2009-05-27 99.028220994475 fty720-r-phosphate FTY720 sphingosines sphingosine-1-phosphates S1P S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 endothelial cells barrier functions immunosuppression FTY-720 FTY 720
10006408 FTY720 (S)-Phosphate 402616-26-6 ≥98% 2009-05-27 132.061325966850 fty720-s-phosphate (S)-FTY 720P FTY720 sphingosines sphingosine-1-phosphate S1P S1P1 S1P3 S1P4 S1P5 immunosuppression immune modulators Abcc1 Abcb1 transporters cPLA2 cytosolic phospholipase A2 endothelial cells barriers functions FTY720P
13332 Glycyl-H-1152 (hydrochloride) 913844-45-8 ≥98% 2010-01-27 81.578635739133 glycyl-h-1152-hydrochloride Rho Kinase Inhibitor IV Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV
13311 Gö 6983 133053-19-7 ≥98% 2009-10-07 28.101503551697 g-6983 proteins kinases C PKC α β γ δ ζ µ hearts cardioprotection ischemia reperfusion injuries contractile dyfunction alpha beta gamma delta zeta micro Goe Goe6983 Go-6983 Go 6983
10136 GPR17 (C-Term) Polyclonal Antibody - 2010-01-19 50.866858118477 gpr17-c-term-polyclonal-antibody G Protein-Coupled Receptor 17 proteins receptors antibodies western blots WB ICC signals signaling nucleotides CysLTs amino acids blotting immunoblotting FC flow cytometry immunocytochemistry cysteinyl leukotrienes
13009 GSK264220A 685506-42-7 ≥98% 2009-10-21 27.099634067590 gsk264220a inhibitors endothelial lipases high-density lipoproteins cholesterol HDL-C HDL cardiovascular diseases inhibition inhibited ET
13345 GYY 4137 Exclusive 106740-09-4 ≥95% ✓ 2009-07-31 16.215911602209 gyy-4137 hydrogen sulfides H2S gaseous mediators nitric oxides NOs donors vasodilator antihypertensive anti-hypertensive rats spontaneously hypertensive hypertension models endotoxic shock TNF-α TNFα TNF α TNF-a TNFa IL-1b IL1b IL-1β IL1β IL-6 IL6 NFkB NF-kB NF-κB NFκB iNOS COX-2 COX2 PGE2 110-91-8 106740-08-3
10007653 H-1152 (hydrochloride) - ≥95% 2010-02-25 112.642857142857 h-1152-hydrochloride Rho kinase ROCK cytoskeletal cytoskeleton smooth muscles contractions vasoconstriction neurons neurite inhibitors Y-27632 HA-1077 PKA PKC MLCK H1152 H 1152 inhibition inhibits 451462-58-1
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 30.874281767956 ha-1077-hydrochloride Eril; Fasudil (hydrochloride) protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers
13624 Icariin 489-32-7 ≥97% 2010-02-11 62.642659719415 icariin PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction
10009458 JTE-013 383150-41-2 >98% 2007-01-18 87.972562154695 jte-013 reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers
10011562 L-655,240 103253-15-2 ≥98% 2009-10-15 16.500481353591 l-655-240 platelet aggregation smooth muscle constriction contraction antagonist receptors TXA2 receptor TP thromboxane TPα TPβ TXA2 bronchoconstriction L-655240 L 655240
10011125 LDL Uptake Cell-Based Assay Kit - 2008-04-29 28.423385951066 ldl-uptake-cell-based-assay-kit Low-Density Lipoprotein Uptake atherosclerosis cholestrols plasmas blood coronary heart diseases low-density lipoproteins kits assays assaying tools uptakes regulation
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 2.077348066299 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes
10010971 Luminex® 11-dehydro Thromboxane B2 Kit - 2008-01-24 52.225662983425 luminex-11-dehydro-thromboxane-b2-kit Luminex® 11-dehydro TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays
600160 Methionine Sulfoxide Immunoblotting Kit - 2009-12-17 143.321805433729 methionine-sulfoxide-immunoblotting-kit MetO Immunoblotting Kit proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18
10010252 Methyl-L-NIO (hydrochloride) 150403-96-6 >98% 2008-02-12 16.686187845304 methyl-l-nio-hydrochloride NOS L-arginine NO nitric oxide nNOS eNOS iNOS inhibitor inhibits inhibition vasodilation inflammation
10010412 MRE-269 Exclusive 475085-57-5 ≥98% ✓ 2008-11-06 64.450011049724 mre-269 MRE269 prostaglandins PGI2 IP receptors inflammation NS-304 NS304 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs prodrugs
10004971 N,N'-Dicyclohexylurea New 2387-23-7 ≥98% 2010-03-17 127.916938305708 n-n-dicyclohexylurea DCU; NSC 17013 hypertension Epoxyeicosatrienoic acids EETs soluble epoxide hydrolase sEH inhibitors inhibits inhibiting PPARα 1,3-dicyclohexylurea dicyclohexylcarbodiamide
10010411 NS-304 475086-01-2 >98% 2008-04-09 56.267127071823 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs
10006803 O-1602 317321-41-8 >98% 2005-09-12 17.105911602209 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant
10006804 O-1821 35482-50-9 >97% 2005-09-12 0.884493554327 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation
10004914 O-1918 536697-79-7 >98% 2005-09-09 3.982550644567 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918
13804 OU749 New 519170-13-9 ≥95% 2010-07-20 0E-12 ou749 γ-Glutamyl transferases γ-glutamyl transpeptidases glutathione markers liver dysfunction alcohol abuses biomarkers diabetes cardiovascular diseases cancers acivicin
10218 PCSK9 Monoclonal Antibody (Clone 15A6) - 2008-10-29 20.020184162063 pcsk9-monoclonal-antibody-clone-15a6 Proprotein Convertase Subtilisin Kexin 9; NARC-1 antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots
100023 Prostaglandin I Synthase (murine) Polyclonal Antibody - 2004-06-30 9.757941988950 prostaglandin-i-synthase-murine-polyclonal-antibody PGIS; Prostacyclin Synthase; PGI Synthase antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting
9000336 (R)-(+)-Acenocoumarol 66556-77-2 ≥98% 2009-06-25 0.202360882592 -r-acenocoumarol (R)-(+)-Nicoumalone; (R)-(+)-Acenocoumarin thrombosis vitamin k warfarin bleeding blood coagulation inhibitors anticoagulants G-23350 Sintrom Sinthrome coumarins
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 349.448176795580 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins
10006415 Ro 48-8071 161582-11-2 >98% 2005-06-01 30.147645027624 ro-48-8071 monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis
9000337 (S)-(−)-Acenocoumarol 66556-78-3 ≥98% 2009-06-25 0.202360882592 -s-acenocoumarol (S)-(-)-Nicoumalone; (S)-(-)-Aceocoumarin thrombosis vitamin k warfarin bleeding blood coagulation inhibitors inhibition inhibits sintrom sinthrome G-23350 G23350
89460 Sclerotiorin 549-23-5 ≥98% 2009-03-11 38.270718232043 sclerotiorin Lipoxygenase-1 inhibitor CETP Grb2 Endothelins ETa ETb LO-1 ETs LOs Penicillium soybean inhibits inhibition antagonism antagonists
10005260 Serine Palmitoyltransferase Polyclonal Antibody - 2004-12-02 14.222235727440 serine-palmitoyltransferase-polyclonal-antibody Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting
10011348 Taprostene (sodium salt) 87440-45-7 ≥98% 2009-11-11 48.179823592130 taprostene-sodium-salt CG 4203; Rheocyclan prostacyclins PGI2 receptors IP IP1 EP4 vascular smooth muscles relaxation analogs potential antagonists tissues preparations CG-4203 CG4203 SE63 SE-63 SE 63
10007565 Tetradecyl Phosphonate 4671-75-4 >98% 2005-10-17 46.953667127072 tetradecyl-phosphonate pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter
10007349 TGX-221 663619-89-4 >98% 2006-02-21 56.985778355540 tgx-221 phosphatidylinositol-3-kinases PI3K catalyzes phosphorylation produces second messengers (3,4)-biphosphates -P2 (3,4,5)-P3 Class 1 p110.alpha. .beta. .delta. .gamma. p85 regulatory subunits cells permeable inhibitors inhibition inhibits ATP binding sites platelets defective thrombus formation antithrombotic therapy atherosclerosis
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 70.520841006752 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IFimmunofluorescence western blots blotting WB immunoblotting
13044 Tranilast 53902-12-8 ≥98% 2008-08-29 14.231767955801 tranilast SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF
10010522 U-46619 Glycine methyl ester - >98% 2008-03-24 292.163591160221 u-46619-glycine-methyl-ester TP receptors agonists inflammations PGH2 endoperoxides thromboxanes vasoconstriction analogs U46619 3 prodrugs forms
10010992 W123 Exclusive - ≥98% ✓ 2008-11-14 104.320184162062 w123 FTY720 sphingosines sphingosine-1-phosphate receptors S1P S1P1 EDG1 EDG-1 inhibitors inhibits inhibition SEW2871 FTY 720 antagonist
13531 (−)-Warfarin 5543-57-7 ≥98% 2009-10-01 0.330211598746 -warfarin (S)-Warfarin anticoagulants hearts attacks strokes clotting blood cardiovascular diseases vitamins K rodenticides warfarins anti-cogulants
13526 (+)-Warfarin 5543-58-8 ≥98% 2009-10-01 0.616153986040 -warfarin (R)-Warfarin anticoagulants hearts attacks strokes clotting blood cardiovascular diseases vitamins K rodenticides warfarins anti-cogulants
13566 (±)-Warfarin 81-81-2 ≥98% 2009-09-29 0.316906337138 -warfarin Coumadin; Zoocoumarin; Coumafene; Athrombine K; WARF 42 anticoagulants heart attacks strokes clotting blood cardiovascular diseases vitamin K rodenticide anti-coagulants racemic mixture liver accumulation accumulates clots
10010421 Zaprinast 37762-06-4 ≥98% 2008-09-18 9.154272559852 zaprinast 2-(o-Propoxyphenyl)-8-azapurin-6-one; M&B 22,948 sildenafil viagra phophodiesterase cGMP PDE5 GRP35 inhibitors inhibits inhibition M&B 22948 55122-20-8
10010947 β-cyano-L-Alanine 6232-19-5 ≥98% 2008-11-11 4.790676795579 -cyano-l-alanine BCA H2S gasotransmitter inhibitors inhibits inhibition CSE vasodilation inflammation sulfides
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article and Newsletter Archives Analysis Tools Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2010 Cayman Chemical Company